Evaluating Vaccine Efficacy Against Severe Acute Respiratory Syndrome Coronavirus 2 Infection

Although interim results from several large, placebo-controlled, phase 3 trials demonstrated high vaccine efficacy (VE) against symptomatic coronavirus disease 2019 (COVID-19), it is unknown how effective the vaccines are in preventing people from becoming asymptomatically infected and potentially s...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Dan-Yu, Gu, Yu, Zeng, Donglin, Janes, Holly E, Gilbert, Peter B
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Invited Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8406869/
https://www.ncbi.nlm.nih.gov/pubmed/34260716
http://dx.doi.org/10.1093/cid/ciab630

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8406869/
https://www.ncbi.nlm.nih.gov/pubmed/34260716
http://dx.doi.org/10.1093/cid/ciab630

Ejemplares similares